United-Guardian, Inc. reported a significant increase in financial performance for the first quarter of 2026, with net sales reaching $2.87 million, a 16% increase from $2.48 million in the same period of 2025. The company's income from operations also rose, amounting to $642,449 compared to $610,922 in the previous year. Net income for the quarter was $818,902, up from $560,895, resulting in earnings per share of $0.18, compared to $0.12 in the prior year. This growth was primarily driven by increased sales of pharmaceutical products, particularly Renacidin, which saw a 24% rise in gross sales.

The company's total costs and expenses increased to $2.23 million from $1.87 million year-over-year, largely due to higher costs associated with pharmaceutical sales, which typically carry higher unit costs. Operating expenses also saw a modest increase of approximately 5%, attributed to higher sales and marketing expenses. Additionally, United-Guardian recognized a settlement income of $303,133 related to a contract manufacturer, which contributed positively to the overall net income.

In terms of operational developments, United-Guardian entered a new distribution agreement with Brenntag Specialties for its Natrajel line of sexual wellness ingredients, expanding its market presence in the U.S., Canada, Mexico, and France. The company is also focusing on increasing the market for Renacidin through an outreach program aimed at healthcare professionals and Pharmacy Benefit Managers. Despite a competitive landscape, particularly from Asian and European manufacturers, the company is committed to enhancing its product offerings and maintaining quality.

Geographically, approximately 22% of sales were made to customers outside the United States, a decrease from 29% in the previous year. The company’s cash and cash equivalents decreased to $735,854 from $1.25 million at the end of 2025, while total assets fell to $12.70 million from $13.11 million. The current ratio improved to 8.1 from 7.3, indicating a stronger liquidity position. Looking ahead, United-Guardian expects to continue leveraging its cash flow for dividend payments, marketable securities, and growth opportunities, while maintaining a focus on operational efficiency and product innovation.

About UNITED GUARDIAN INC

United-Guardian, Inc. specializes in manufacturing and developing specialty cosmetic ingredients, pharmaceuticals, medical lubricants, and sexual wellness products. The company focuses on innovative, environmentally friendly formulations, serving global markets through distributor partnerships. Its core value lies in product innovation, quality, and reliability, with a business model centered on research, proprietary formulations, and strategic distribution to healthcare, personal care, and sexual wellness sectors.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.